IL71546A - Antiprotozoal potentiating compositions comprising 1,4-naphthoquinones in combination with 4-pyridinols - Google Patents

Antiprotozoal potentiating compositions comprising 1,4-naphthoquinones in combination with 4-pyridinols

Info

Publication number
IL71546A
IL71546A IL71546A IL7154684A IL71546A IL 71546 A IL71546 A IL 71546A IL 71546 A IL71546 A IL 71546A IL 7154684 A IL7154684 A IL 7154684A IL 71546 A IL71546 A IL 71546A
Authority
IL
Israel
Prior art keywords
antiprotozoal
combination
pyridinols
naphthoquinones
potentiating
Prior art date
Application number
IL71546A
Other languages
English (en)
Other versions
IL71546A0 (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IL71546A0 publication Critical patent/IL71546A0/xx
Publication of IL71546A publication Critical patent/IL71546A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Laminated Bodies (AREA)
  • Cosmetics (AREA)
IL71546A 1983-04-14 1984-04-13 Antiprotozoal potentiating compositions comprising 1,4-naphthoquinones in combination with 4-pyridinols IL71546A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838310140A GB8310140D0 (en) 1983-04-14 1983-04-14 Antiprotozoal agents

Publications (2)

Publication Number Publication Date
IL71546A0 IL71546A0 (en) 1984-07-31
IL71546A true IL71546A (en) 1987-08-31

Family

ID=10541104

Family Applications (1)

Application Number Title Priority Date Filing Date
IL71546A IL71546A (en) 1983-04-14 1984-04-13 Antiprotozoal potentiating compositions comprising 1,4-naphthoquinones in combination with 4-pyridinols

Country Status (13)

Country Link
US (1) US5053418A (fr)
EP (2) EP0401875B1 (fr)
JP (1) JPS59205316A (fr)
AT (2) ATE67089T1 (fr)
AU (1) AU574354B2 (fr)
CY (1) CY1862A (fr)
DE (2) DE3485033D1 (fr)
GB (1) GB8310140D0 (fr)
HK (1) HK129695A (fr)
IL (1) IL71546A (fr)
PH (1) PH22010A (fr)
UY (1) UY24036A1 (fr)
ZA (1) ZA842796B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8500292D0 (en) * 1985-01-07 1985-02-13 Wellcome Found Treatment of babesiosis
US5225184A (en) * 1988-08-16 1993-07-06 Burroughs Wellcome Co. Medicaments
GB8819477D0 (en) * 1988-08-16 1988-09-21 Wellcome Found Medicaments
AU633836B2 (en) * 1988-08-16 1993-02-11 Wellcome Foundation Limited, The Medicaments
US5206268A (en) * 1988-08-16 1993-04-27 Burroughs Wellcome Co. Medicaments
GB8921516D0 (en) * 1989-09-22 1989-11-08 Wellcome Found Medicaments
EP0567162A1 (fr) * 1989-09-22 1993-10-27 The Wellcome Foundation Limited Médicaments pour le traitement de la toxoplasmose
GB8923254D0 (en) * 1989-10-16 1989-12-06 Wellcome Found Medicaments
GB9005518D0 (en) * 1990-03-12 1990-05-09 Wellcome Found Heterocyclic compounds
US5403934A (en) * 1990-03-12 1995-04-04 Burroughs Wellcome Co. Heterocyclic compounds
GB9126874D0 (en) * 1991-12-18 1992-02-19 Wellcome Found Medicaments
GB9216859D0 (en) * 1992-08-07 1992-09-23 Wellcome Found Medicaments
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9226905D0 (en) * 1992-12-24 1993-02-17 Wellcome Found Pharmaceutical preparation
GB9410299D0 (en) * 1994-05-20 1994-07-13 British Tech Group Naphthoquinone derivatives
US5684035A (en) * 1996-07-17 1997-11-04 Kapadia; Govind J. Antimalarial agents
BRPI0513951A (pt) * 2004-07-30 2008-05-20 Japan Health Science Found agente antiprotozoário
EP2246329A1 (fr) 2009-01-19 2010-11-03 Glaxo Group Limited Dérivés de la 4(1H)-pyridinone et leur utilisation contre la malaria
WO2010081904A1 (fr) 2009-01-19 2010-07-22 Glaxo Group Limited Dérivés de 4(1h)-pyridinone et leur utilisation comme agents antipaludiques
EP2408467A2 (fr) * 2009-03-20 2012-01-25 University Of South Florida Procédé et composition utilisant une protéine tyrosine phosphatase à double spécificité en tant que cible de médicament antipaludéen

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2553647A (en) * 1946-03-20 1951-05-22 Research Corp Naphthoquinone antimalarials
US2553648A (en) 1948-01-08 1951-05-22 Research Corp Naphthoquinone compounds
NL124395C (fr) 1963-09-25
US3347742A (en) 1965-05-28 1967-10-17 Merck & Co Inc 2-(4-cyclohexylcyclohexyl)-3-hydroxy-1, 4-naphthoquinone in controlling coccidiosis in poultry
US3367830A (en) 1965-06-23 1968-02-06 Merck & Co Inc Controlling coccidiosis in poultry with 1,4-naphthoquinones
AU458235B2 (en) * 1971-02-09 1975-02-20 Shionogi & Co., Ltd Quinone derivatives and compositions containing thesame
FI762480A (fr) 1975-09-15 1977-03-16 Du Pont
GB1553424A (en) 1976-02-10 1979-09-26 Wellcome Found Method of treating protozal diseases
EG14152A (en) 1977-11-22 1983-12-31 Wellcome Found Antitheilerial naphtoquinone derivatives
US4485116A (en) 1981-10-16 1984-11-27 Hudson Alan T Antiprotozoal compounds
US4485117A (en) * 1981-10-16 1984-11-27 Hudson Alan T Antiprotozoal compounds
GB8310141D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Naphthoquinone derivatives

Also Published As

Publication number Publication date
CY1862A (en) 1996-04-05
DE3486189D1 (de) 1993-09-02
JPH0481568B2 (fr) 1992-12-24
EP0401875A3 (en) 1990-12-27
UY24036A1 (es) 1995-09-18
EP0123239A3 (en) 1987-11-25
AU574354B2 (en) 1988-07-07
DE3485033D1 (de) 1991-10-17
EP0123239A2 (fr) 1984-10-31
ATE67089T1 (de) 1991-09-15
US5053418A (en) 1991-10-01
ATE91892T1 (de) 1993-08-15
GB8310140D0 (en) 1983-05-18
DE3486189T2 (de) 1994-03-03
HK129695A (en) 1995-08-24
IL71546A0 (en) 1984-07-31
EP0123239B1 (fr) 1991-09-11
EP0401875B1 (fr) 1993-07-28
PH22010A (en) 1988-05-02
JPS59205316A (ja) 1984-11-20
EP0401875A2 (fr) 1990-12-12
AU2679784A (en) 1984-10-18
ZA842796B (en) 1985-11-27

Similar Documents

Publication Publication Date Title
IL71546A (en) Antiprotozoal potentiating compositions comprising 1,4-naphthoquinones in combination with 4-pyridinols
ZA853323B (en) Compositions for the treatment of fruit and vegetables by thermonebulisation and processing method using said composition
ES2014060A6 (es) Procedimiento para la obtencion de productos farmaceuticos que actuan en particualr sobre el corazon y el sistema cardiovascular.
ES481235A1 (es) Un procedimiento para la preparacion de 6 cloro-2,3-dihidro-xi-1, 4-naftoquinona y sus 2,3-diesteres.
GB8326130D0 (en) Topical preparations containing tars and fatty acids
MY100883A (en) The use of salicylic acid esters as perfumes, perfume compositions containing them and new salicylic esters.
ES2009248A6 (es) Composicion dietetica a base de algas que contengan selenio.
NZ223293A (en) Beta-alkyl melatonins and pharmaceutical compositions
ES2009569A6 (es) Procedimiento de preparacion de una composicion farmaceutica a base de algas que contengan selenio que actua sobre el corazon y el sistema cardiovascular.
CA1262912C (fr) Derives de substitution tetrahydrofuranyliques d'analogues de la prostaglandine
EP0137301A3 (en) 2-ketocarboxylic-acid reductase, its preparation and its use
IT8621321A0 (it) Macchina da banco per la distribuzione di prodotti per spuntini.
ES8102092A1 (es) Procedimiento de preparacion de monohidrato de 1,25-dihidro-xi-colecalciferol
ES8606259A1 (es) Un metodo de producir una composicion farmaceutica que contiene isoxicamato de l-arginina como ingrediente activo.
ES8702162A1 (es) Procedimiento para preparar composiciones autoemulsionables a base de fluoroclorohidrocarburos y de esteres fosforicos
MW1184A1 (en) Improving the nutritive value of products pim 509, 512, 515, 532, 524, 525, 537
JPS5361258A (en) Current source buffer using fet
JPS51126064A (en) Lead frame material
IT8524124V0 (it) Cassonetto metallico modulare per la composizione di mobili.
BG52067B2 (en) Antihypoxic and brain-protection antidote composition
UA43470A1 (uk) Склад для пригнічування пилу
JPS51119930A (en) Rectifier
SU1172285A1 (ru) Сплав на основе алюминия
KE3356A (en) Cyclopropanecarboxylic acid esters,their preparatiprocess for obtaining corn oil from corn germs andon and their use as pest-combating agents corn oil thus obtained
AU88858S (en) Car bonnet

Legal Events

Date Code Title Description
RH Patent void